Improving cancer immunotherapy by targeting the STATe of MDSCs

Cancer immunotherapy is a promising therapeutic avenue; however, in practice its efficacy is hampered by an immunosuppressive tumor microenvironment that consists of suppressive cell types like myeloid-derived suppressor cells (MDSCs). Eradication or reprogramming of MDSCs could therefore enhance cl...

Descripción completa

Detalles Bibliográficos
Autores principales: de Haas, Nienke, de Koning, Coco, Spilgies, Lisanne, de Vries, I. Jolanda M., Hato, Stanleyson V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006927/
https://www.ncbi.nlm.nih.gov/pubmed/27622051
http://dx.doi.org/10.1080/2162402X.2016.1196312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006927/
https://www.ncbi.nlm.nih.gov/pubmed/27622051
http://dx.doi.org/10.1080/2162402X.2016.1196312

Ejemplares similares